<DOC>
	<DOCNO>NCT02708355</DOCNO>
	<brief_summary>The purpose pilot study investigate association gastric acid suppression relief 24 hour heartburn follow treatment proton pump inhibitor ( PPI ) drug esomeprazole frequent heartburn patient .</brief_summary>
	<brief_title>Pilot Study To Investigate The Association Between Acid Control And Heartburn Symptoms After Proton Pump Inhibitor Treatment</brief_title>
	<detailed_description />
	<mesh_term>Heartburn</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Confirmed symptom history heartburn , acid regurgitation , epigastric pain least 3 month , treat gastric acid modulate therapy ( antacid , H2 receptor antagonist ( H2RAs ) and/or PPIs ) . Heartburn symptoms average 3 time per week great include least 2 episode nighttime heartburn symptom per week past 30 day . When heartburn medication use , subject heartburn symptom responsive antacid , non prescription H2RAs , short term non prescription prescription PPIs approve dos complete resolution heartburn achieve . A history ( past present ) erosive esophagitis verify endoscopy . The need continuous treatment H2RAs , PPIs , gastric prokinetic drug , antacid indication study ( eg , long term prescription therapy ) . Subjects require continuous intervention physician treatment GERD ( ie , treatment erosive esophagitis prevention relapse heal esophagitis ) .</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>